The latest price target for Hologic (NASDAQ:HOLX) was reported by Morgan Stanley on January 13, 2025. The analyst firm set a price target for $82.00 expecting HOLX to rise to within 12 months (a possible 13.62% upside). 33 analyst firms have reported ratings in the last year.

The latest analyst rating for Hologic (NASDAQ:HOLX) was provided by Morgan Stanley, and Hologic maintained their equal-weight rating.

The last upgrade for Hologic Inc happened on April 3, 2024 when Citigroup raised their price target to $95. Citigroup previously had a neutral for Hologic Inc.

The last downgrade for Hologic Inc happened on October 1, 2024 when Citigroup changed their price target from $95 to $85 for Hologic Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hologic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hologic was filed on January 13, 2025 so you should expect the next rating to be made available sometime around January 13, 2026.

While ratings are subjective and will change, the latest Hologic (HOLX) rating was a maintained with a price target of $84.00 to $82.00. The current price Hologic (HOLX) is trading at is $72.17, which is out of the analyst’s predicted range.